These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 23747515)
1. Identification of tubulin beta chain, thymosin beta-4-like protein 3, and cytochrome b-c₁ complex subunit 1 as serological diagnostic biomarkers of gastric cancer. Fan NJ; Li K; Liu QY; Wang XL; Hu L; Li JT; Gao CF Clin Biochem; 2013 Oct; 46(15):1578-84. PubMed ID: 23747515 [TBL] [Abstract][Full Text] [Related]
2. Tubulin beta chain, filamin A alpha isoform 1, and cytochrome b-c1 complex subunit 1 as serological diagnostic biomarkers of esophageal squamous cell carcinoma: a proteomics study. Fan NJ; Gao CF; Wang XL OMICS; 2013 Apr; 17(4):215-23. PubMed ID: 23496306 [TBL] [Abstract][Full Text] [Related]
3. Identification alpha-2-HS-glycoprotein precursor and tubulin beta chain as serology diagnosis biomarker of colorectal cancer. Fan NJ; Kang R; Ge XY; Li M; Liu Y; Chen HM; Gao CF Diagn Pathol; 2014 Mar; 9():53. PubMed ID: 24618180 [TBL] [Abstract][Full Text] [Related]
4. Identification and validation of novel candidate protein biomarkers for the detection of human gastric cancer. Humphries JM; Penno MA; Weiland F; Klingler-Hoffmann M; Zuber A; Boussioutas A; Ernst M; Hoffmann P Biochim Biophys Acta; 2014 May; 1844(5):1051-8. PubMed ID: 24512919 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic role of serum protein peak at 6449 m/z in gastric adenocarcinoma based on mass spectrometry. Song D; Yue L; Li H; Zhang J; Yan Z; Fan Y; Yang H; Liu Q; Zhang D; Xia Z; Qin P; Jia J; Yue M; Yu J; Zheng S; Yang F; Wang J Br J Cancer; 2016 Apr; 114(8):929-38. PubMed ID: 27002935 [TBL] [Abstract][Full Text] [Related]
6. Identification of carboxyl terminal peptide of Fibrinogen as a potential serum biomarker for gastric cancer. Wu C; Luo Z; Tang D; Liu L; Yao D; Zhu L; Wang Z Tumour Biol; 2016 May; 37(5):6963-70. PubMed ID: 26662807 [TBL] [Abstract][Full Text] [Related]
7. Serum angiopoietin-like protein 2 as a potential biomarker for diagnosis, early recurrence and prognosis in gastric cancer patients. Toiyama Y; Tanaka K; Kitajima T; Shimura T; Imaoka H; Mori K; Okigami M; Yasuda H; Okugawa Y; Saigusa S; Ohi M; Inoue Y; Mohri Y; Goel A; Kusunoki M Carcinogenesis; 2015 Dec; 36(12):1474-83. PubMed ID: 26420253 [TBL] [Abstract][Full Text] [Related]
8. Serum peptide mapping in gastric precancerous lesion and cancer. Li P; Ma D; Zhu ST; Tang XD; Zhang ST J Dig Dis; 2014 May; 15(5):239-45. PubMed ID: 24438315 [TBL] [Abstract][Full Text] [Related]
9. Diagnosis of gastric cancer by serum proteomic fingerprinting. Poon TC; Sung JJ; Chow SM; Ng EK; Yu AC; Chu ES; Hui AM; Leung WK Gastroenterology; 2006 May; 130(6):1858-64. PubMed ID: 16697748 [TBL] [Abstract][Full Text] [Related]
10. Identification of 14‑3‑3ζ as a potential biomarker in gastric cancer by proteomics‑based analysis. Liu XX; Ye H; Wang P; Zhang Y; Zhang JY Mol Med Rep; 2017 Nov; 16(5):7759-7765. PubMed ID: 28944820 [TBL] [Abstract][Full Text] [Related]
11. Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer. Lu HB; Zhou JH; Ma YY; Lu HL; Tang YL; Zhang QY; Zhao CH Jpn J Clin Oncol; 2010 Apr; 40(4):336-42. PubMed ID: 20089528 [TBL] [Abstract][Full Text] [Related]
12. Identification of peptide regions of SERPINA1 and ENOSF1 and their protein expression as potential serum biomarkers for gastric cancer. Yang J; Xiong X; Wang X; Guo B; He K; Huang C Tumour Biol; 2015 Jul; 36(7):5109-18. PubMed ID: 25677901 [TBL] [Abstract][Full Text] [Related]
13. New blood markers detection technology: A leap in the diagnosis of gastric cancer. Beeharry MK; Liu WT; Yan M; Zhu ZG World J Gastroenterol; 2016 Jan; 22(3):1202-12. PubMed ID: 26811658 [TBL] [Abstract][Full Text] [Related]
14. S100A9, GIF and AAT as potential combinatorial biomarkers in gastric cancer diagnosis and prognosis. Wu W; Juan WC; Liang CR; Yeoh KG; So J; Chung MC Proteomics Clin Appl; 2012 Apr; 6(3-4):152-62. PubMed ID: 22532451 [TBL] [Abstract][Full Text] [Related]
15. Analysis of variabilities of serum proteomic spectra in patients with gastric cancer before and after operation. Ren H; Du N; Liu G; Hu HT; Tian W; Deng ZP; Shi JS World J Gastroenterol; 2006 May; 12(17):2789-92. PubMed ID: 16718772 [TBL] [Abstract][Full Text] [Related]
16. From proteomic multimarker profiling to interesting proteins: thymosin-β(4) and kininogen-1 as new potential biomarkers for inflammatory hepatic lesions. Henkel C; Schwamborn K; Zimmermann HW; Tacke F; Kühnen E; Odenthal M; Groseclose MR; Caprioli RM; Weiskirchen R J Cell Mol Med; 2011 Oct; 15(10):2176-88. PubMed ID: 21496200 [TBL] [Abstract][Full Text] [Related]
17. Discovery of gastric cancer specific biomarkers by the application of serum proteomics. Yoo MW; Park J; Han HS; Yun YM; Kang JW; Choi DY; Lee JW; Jung JH; Lee KY; Kim KP Proteomics; 2017 Mar; 17(6):. PubMed ID: 28133907 [TBL] [Abstract][Full Text] [Related]
18. Absence of beta-tubulin gene mutation in gastric carcinoma. Urano N; Fujiwara Y; Hasegawa S; Miyoshi Y; Noguchi S; Takiguchi S; Yasuda T; Yano M; Monden M Gastric Cancer; 2003; 6(2):108-12. PubMed ID: 12861402 [TBL] [Abstract][Full Text] [Related]
19. [Protein profiles of serum in gastric cancer at a high-risk area by SELDI-TOF mass spectrometry]. Wang YS; Shen J; Yu JK; Zhang L; Ma JL; You WC; Pan KF Zhonghua Yu Fang Yi Xue Za Zhi; 2008 Sep; 42(9):677-80. PubMed ID: 19175180 [TBL] [Abstract][Full Text] [Related]
20. In situ proteomic analysis by MALDI imaging identifies ubiquitin and thymosin-β4 as markers of malignant intraductal pancreatic mucinous neoplasms. Rebours V; Le Faouder J; Laouirem S; Mebarki M; Albuquerque M; Camadro JM; Léger T; Ruszniewski P; Lévy P; Paradis V; Bedossa P; Couvelard A Pancreatology; 2014; 14(2):117-24. PubMed ID: 24650966 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]